Related references
Note: Only part of the references are listed.Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study
Walter Cazzaniga et al.
BJU INTERNATIONAL (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden
Walter Cazzaniga et al.
FRONTIERS IN MEDICINE (2019)
Public online reporting from a nationwide population-based clinical prostate cancer register
Par Stattin et al.
BJU INTERNATIONAL (2018)
Dose Response and Fractionation Sensitivity of Prostate Cancer After External Beam Radiation Therapy: A Meta-analysis of Randomized Trials
Ivan R. Vogelius et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
Martin G. Sanda et al.
JOURNAL OF UROLOGY (2018)
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M. Michalski et al.
JAMA ONCOLOGY (2018)
Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer
Skyler B. Johnson et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
What is the best way to radiate the prostate in 2016?
Dominic H. Moon et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
Stacy Loeb et al.
JAMA ONCOLOGY (2017)
Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base-a refined prostate cancer trajectory
Mieke Van Hemelrijck et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer
Nicholas G. Zaorsky et al.
CANCER TREATMENT REVIEWS (2016)
Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7
Sophie D. Fossa et al.
EUROPEAN UROLOGY (2016)
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W. Robert Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
Luca Incrocci et al.
LANCET ONCOLOGY (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
A national approach for automated collection of standardized and population-based radiation therapy data in Sweden
Tufve Nyholm et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Evaluation of data quality in the National Prostate Cancer Register of Sweden
Katarina Tomic et al.
EUROPEAN JOURNAL OF CANCER (2015)
The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
Beata Smolska-Ciszewska et al.
RADIATION ONCOLOGY (2015)
Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer
Anusha Kalbasi et al.
JAMA ONCOLOGY (2015)
Capture rate and representativity of The National Prostate Cancer Register of Sweden
Katarina Tomic et al.
ACTA ONCOLOGICA (2015)
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2014)
Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up
A. Creak et al.
BRITISH JOURNAL OF CANCER (2013)
Treatment of early-stage prostate cancer among rural and urban patients
Laura-Mae Baldwin et al.
CANCER (2013)
Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
Mieke Van Hemelrijck et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
David Dearnaley et al.
LANCET ONCOLOGY (2012)
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
Silvia Johansson et al.
PROSTATE CANCER (2012)
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
Christopher U. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort
Kerri Beckmann et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2009)
HIGHER-THAN-CONVENTIONAL RADIATION DOSES IN LOCALIZED PROSTATE CANCER TREATMENT: A META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
Gustavo Arruda Viani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Anders Widmark et al.
LANCET (2009)
Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review
Bradley R. Pieters et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610
Mack Roach et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
STH Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A comparison of observational studies and randomized, controlled trials.
K Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
